Advanced search
Publication Cover
Pharmacogenomics Volume 13, 2012 - Issue 13
Submit an article Journal homepage
218
Views
0
CrossRef citations to date
0
Altmetric
Research Article

TNF-α -857 and -1031 Polymorphisms Predict Good Therapeutic Response to TNF-α Blockers in Chinese Han Patients with Ankylosing Spondylitis

Qiang Tong1 Department of Rheumatology & Immunology, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Yangpu District, Shanghai200433, ChinaView further author information
,
Dong-Bao Zhao1 Department of Rheumatology & Immunology, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Yangpu District, Shanghai200433, ChinaView further author information
,
Punam Bajracharya2 Department of Internal Medicine, Shree Birendra Hospital, Kathmandu, NepalView further author information
,
Xia Xu1 Department of Rheumatology & Immunology, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Yangpu District, Shanghai200433, ChinaView further author information
,
Rui-Na Kong1 Department of Rheumatology & Immunology, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Yangpu District, Shanghai200433, ChinaView further author information
,
Ju Zhang1 Department of Rheumatology & Immunology, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Yangpu District, Shanghai200433, ChinaView further author information
,
Sheng-Ming Dai1 Department of Rheumatology & Immunology, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Yangpu District, Shanghai200433, ChinaView further author information
&
Qing Cai1 Department of Rheumatology & Immunology, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Yangpu District, Shanghai200433, China;1 Department of Rheumatology & Immunology, Changhai Hospital, Second Military Medical University, 168 Changhai Road, Yangpu District, Shanghai200433, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1459-1467 | Published online: 12 Oct 2012

References

  • Huang F , ZhangJ, HuangJL et al. A multicenter, double-blind, placebo-controlled, randomized, Phase III clinical study of etanercept in treatment of ankylosing spondylitis. Chin. J. Intern. Med. 49(9) , 741–745 (2010).
  • Pavy S , ToonenEJ, Miceli-RichardC et al. Tumour necrosis factor α -308G->A polymorphism is not associated with response to TNF α blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis. Ann. Rheum. Dis 69(6) , 1022–1028 (2010).
  • Seitz M , WirthmüllerU, MöllerB, VilligerPM. The -308 tumour necrosis factor-α gene polymorphism predicts therapeutic response to TNF α-blockers in rheumatoid arthritis and spondyloarthritis patients. Rheumatology (Oxford)46(1) , 93–96 (2007).
  • Lee YH , JiJD, BaeSC, SongGG. Associations between tumor necrosis factor-α (TNF-α) -308 and -238 G/A polymorphisms and shared epitope status and responsiveness to TNF-α blockers in rheumatoid arthritis: a metaanalysis update. J. Rheumatol.37(4) , 740–746 (2010).
  • Ingegnoli F , FavalliEG, MeroniPL. Does polymorphysm of genes coding for pro-inflammatory mediators predict the clinical response to TNF α blocking agents? A review analysis of the literature. Autoimmun. Rev.10(8) , 460–463 (2011).
  • Liu C , BatliwallaF, LiW et al. Genome-wide association scan identifies candidate polymorphisms associated with differential response to anti-TNF treatment in rheumatoid arthritis. Mol. Med. 14(9–10) , 575–581 (2008).
  • Lequerré T , VittecoqO, Le Loët X. Comments about the editorial by Bénédicte Mugnier and Jean Roudier entitled “Factors predicting responsiveness to anti-TNFalpha therapy in patients with rheumatoid arthritis: using biotherapies rationally”. Joint Bone Spine72(4) , 346–347 (2005).
  • Balog A , KlauszG, GálJ et al. Investigation of the prognostic value of TNF-α gene polymorphism among patients treated with infliximab, and the effects of infliximab therapy on TNF-α production and apoptosis. Pathobiology 71(5) , 274–280 (2004).
  • Vasilopoulos Y , ManolikaM, ZafiriouE et al. Pharmacogenetic analysis of TNF, TNFRSF1A, and TNFRSF1B gene polymorphisms and prediction of response to anti-TNF therapy in psoriasis patients in the Greek population. Mol. Diagn. Ther. 16(1) , 29–34 (2012).
  • Prajapati R , PlantD, BartonA. Genetic and genomic predictors of anti-TNF response. Pharmacogenomics12(11) , 1571–1585 (2011).
  • Sousa E , Caetano-LopesJ, PintoP et al. Ankylosing spondylitis susceptibility and severity – contribution of TNF gene promoter polymorphisms at positions -238 and -308. Ann. NY Acad. Sci. 1173 , 581–588 (2009).
  • Fonseca JE , CarvalhoT, CruzM et al. Polymorphism at position -308 of the tumour necrosis factor α gene and rheumatoid arthritis pharmacogenetics. Ann. Rheum. Dis 64(5) , 793–794 (2005).
  • Lee YH , SongGG. Lack of association of TNF-α promoter polymorphisms with ankylosing spondylitis: a meta-analysis. Rheumatology (Oxford)48(11) , 1359–1362 (2009).
  • Romero-Sánchez C , LondoñoJ, DelgadoG et al. Association of tumor necrosis factor α-308 promoter polymorphism with spondyloarthritides patients in Colombia. Rheumatol. Int. 32(7) , 2195–2197 (2012).
  • Chatzikyriakidou A , GeorgiouI, VoulgariPV, DrososAA. The role of tumor necrosis factor (TNF)-α and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis. Clin. Exp. Rheumatol.27(4) , 645–648 (2009).
  • Li B , WangP, LiH. The association between TNF-α promoter polymorphisms and ankylosing spondylitis: a meta-analysis. Clin. Rheumatol.29(9) , 983–990 (2010).
  • Poddubnyy DA , Märker-HermannE, Kaluza-SchillingW et al. Relation of HLA-B27, tumor necrosis factor-α promoter gene polymorphisms, and T cell cytokine production in ankylosing spondylitis – a comprehensive genotype–phenotype analysis from an observational cohort. J. Rheumatol. 38(11) , 2436–2441 (2011).
  • Zinovieva E , BourgainC, KadiA et al. Comprehensive linkage and association analyses identify haplotype, near to the TNFSF15 gene, significantly associated with spondyloarthritis. PLoS Genet. 5(6) , e1000528 (2009).
  • Lu MC , YangKL, TungCH et al. Higher LPS-stimulated TNF-α mRNA levels in peripheral blood mononuclear cells from Chinese ankylosing spondylitis patients with -308G/A polymorphism in promoter region of tumor necrosis factor: association with distinct A33/B58/Cw10haplotypes. Rheumatol. Int. 29(2) , 189–195 (2008).
  • Brown MA . Re: Zhu et al, “A novel gene variation of TNF alpha associated with ankylosing spondylitis: a reconfirmed study”. Ann. Rheum. Dis67(3) , 434; discussion 434–436 (2008).
  • Nicknam MH , MahmoudiM, AmirzargarAA, JamshidiAR, RezaeiN, NikbinB. HLA-B27 subtypes and tumor necrosis factor α promoter region polymorphism in Iranian patients with ankylosing spondylitis. Eur. Cytokine Netw.20(1) , 17–20 (2009).
  • Shiau MY , LoMK, ChangCP, YangTP, HoKT, ChangYH. Association of tumour necrosis factor α promoter polymorphisms with ankylosing spondylitis in Taiwan. Ann. Rheum. Dis66(4) , 562–563 (2007).
  • Vargas-Alarcón G , Casasola-VargasJ, Rodríguez-PérezJM et al. Tumor necrosis factor-α promoter polymorphisms in Mexican patients with spondyloarthritis. Hum. Immunol. 67(10) , 826–832 (2006).
  • Davidson SI , LiuY, DanoyPA et al. Association of STAT3 and TNFRSF1A with AS in Han Chinese; ARD 2011 – investigating the susceptibility to AS in Han Chinese. Ann. Rheum. Dis 70(2) , 289–292 (2011).
  • Huang F , ZhangF, ZhengY et al. A multicenter, double-blind, randomized, placebo-controlled clinical trial of etanercept treatment of Chinese patients with active ankylosing spondylitis. Chin. J. Intern. Med. 50(12) , 1043–1047 (2011).
  • Van der Linden S , ValkenburgHA, CatsA. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum.27(4) , 361–368 (1984).
  • Garrett S , JenkinsonT, KennedyLG et al. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J. Rheumatol. 21(12) , 2286–2291 (1994).
  • Anderson JJ , BaronG, van der Heijde D et al. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum.44(8) , 1876–1886 (2001).
  • Chung WT , ChoeJY, JangWC et al. Polymorphisms of tumor necrosis factor-α promoter region for susceptibility to HLA-B27-positive ankylosing spondylitis in Korean population. Rheumatol. Int. 31(9) , 1167–1175 (2011).
  • Marotte H , ArnaudB, DiasparraJ, ZrioualS, MiossecP. Association between the level of circulating bioactive tumor necrosis factor α and the tumor necrosis factor α gene polymorphism at -308 in patients with rheumatoid arthritis treated with a tumor necrosis factor α inhibitor. Arthritis Rheum.58(5) , 1258–1263 (2008).
  • Kooloos WM , WesselsJA, van der Straaten T, Huizinga TW, Guchelaar HJ. Criteria for the selection of single nucleotide polymorphisms in pathway pharmacogenetics: TNF inhibitors as a case study. Drug Discov. Today14(17–18) , 837–844 (2009).
  • Lv K , ChenR, CaiQ, FangM, SunS. Effects of a single nucleotide polymorphism on the expression of human tumor necrosis factor-α. Scand. J. Immunol.64(2) , 164–169 (2006).
  • Guis S , BalandraudN, BouvenotJ et al. Influence of -308 A/G polymorphism in the tumor necrosis factor α gene on etanercept treatment in rheumatoid arthritis. Arthritis Rheum. 57(8) , 1426–1430 (2007).
  • Aguillón JC , CruzatA, AravenaO, SalazarL, LlanosC, CuchacovichM. Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution? Immunobiology211(1–2) , 75–84 (2006).
  • Soto L , SabugoF, CatalanD et al. The presence of anti-citrullinated protein antibodies (ACPA) does not affect the clinical response to adalimumab in a group of RA patients with the tumor necrosis factor (TNF) α-308 G/G promoter polymorphism. Clin. Rheumatol. 30(3) , 391–395 (2011).
  • Plant D , BowesJ, PotterC et al. Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci. Arthritis Rheum. 63(3) , 645–653 (2011).
  • Suarez-Gestal M , Perez-PampinE, CalazaM, Gomez-ReinoJJ, Gonzalez.A Lack of replication of genetic predictors for the rheumatoid arthritis response to anti-TNF treatments: a prospective case-only study. Arthritis Res. Ther.12(2) , R72 (2010).
  • Potter C , GibbonsLJ, BowesJD et al. Polymorphisms spanning the TNFR2 and TACE genes do not contribute towards variable anti-TNF treatment response. Pharmacogenet. Genomics 20(5) , 338–341 (2010).
  • O‘Rielly DD , RoslinNM, BeyeneJ, PopeA, RahmanP. TNF-α-308 G/A polymorphism and responsiveness to TNF-α blockade therapy in moderate to severe rheumatoid arthritis: a systematic review and meta-analysis. Pharmacogenomics J.9(3) , 161–167 (2009).
  • Maxwell JR , PotterC, HyrichKL et al. Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis. Hum. Mol. Genet. 17(22) , 3532–3538 (2008).
  • Ongaro A , De Mattei M, Pellati A et al. Can tumor necrosis factor receptor II gene 676T>G polymorphism predict the response grading to anti-TNFα therapy in rheumatoid arthritis? Rheumatol. Int.28(9) , 901–908 (2008).
  • Kang CP , LeeKW, YooDH, KangC, BaeSC. The influence of a polymorphism at position -857 of the tumour necrosis factor a gene on clinical response to etanercept therapy in rheumatoid arthritis. Rheumatology44(4) , 547–552 (2005).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.